Effects of resistance training on the glycemic control of people with type 1 diabetes: a systematic review and meta-analysis
Resistance training has shown the potential to contribute to better glycemic control in people with Type 1 Diabetes (T1D), however, there are contradictory results in this regard and a need to clarify the effects of isolated resistance training on glycemic control in T1D. The aim was to verify the e...
Saved in:
Published in | Archives of Endocrinology and Metabolism Vol. 66; no. 4; pp. 533 - 540 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Sociedade Brasileira de Endocrinologia e Metabologia
01.07.2022
Brazilian Society of Endocrinology and Metabolism |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Resistance training has shown the potential to contribute to better glycemic control in people with Type 1 Diabetes (T1D), however, there are contradictory results in this regard and a need to clarify the effects of isolated resistance training on glycemic control in T1D. The aim was to verify the effects of resistance training on the glycemic control of people with T1D. Original articles were selected, randomized and non-randomized clinical trials that aimed to verify chronic responses, through the concentrations of glycated hemoglobin (HbA1c), to a structured program of resistance exercise in the glycemia of patients with T1D. The following databases were searched; MEDLINE, PubMed, Web of Science, Scopus, ScienceDirect, LILACS, and SciELO. Five studies were included in the review. A reduction in HbA1c was observed (SMD = -0.568 ± 0.165 [95% CI = -0.891 to -0.246]; p = 0.001; I² = 82%) in patients undergoing resistance training, when compared to the control group (SMD = 1.006 ± 0.181 [95% CI = 0.653 to 1.360]; p <0.001). Two studies, with children and adolescents and longer interventions, demonstrated a significant reduction in HbA1c, increased strength, and an improved lipid profile. Resistance training was efficient for assisting in glycemic control in people with T1D and should be incorporated in treatment plans. |
---|---|
Bibliography: | Disclosure: no potential conflict of interest relevant to this article was reported. Authors’ contributions: Author Valderi Abreu de Lima, Francisco José de Menezes Junior, and Luana da Rocha Celli made substantial contributions to the conception or the design of the manuscript, Suzana Nesi França, Gabriel Ribeiro Cordeiro, Luis Paulo Gomes Mascarenhas, and Neiva Leite, to acquisition, analysis, and interpretation of the data. All authors participated in drafting the manuscript. All authors read and approved the final version of the manuscript. |
ISSN: | 2359-3997 2359-4292 |
DOI: | 10.20945/2359-3997000000487 |